Science & patent news

Cooperative electrocatalytic alcohol oxidation with electron-proton-transfer mediators

The electrochemical oxidation of alcohols is a major focus of energy and chemical conversion efforts, with potential applications ranging from fuel cells to biomass utilization and fine-chemical synthesis. Small-molecule electrocatalysts for processes of this type are promising targets for further development, as demonstrated by recent advances in nickel catalysts for electrochemical production and oxidation of hydrogen. Complexes with tethered amines that resemble the active...

More Comments are closed
Cooperative electrocatalytic alcohol oxidation with electron-proton-transfer mediators

The electrochemical oxidation of alcohols is a major focus of energy and chemical conversion efforts, with potential applications ranging from fuel cells to biomass utilization and fine-chemical synthesis. Small-molecule electrocatalysts for processes of this type are promising targets for further development, as demonstrated by recent advances in nickel catalysts for electrochemical production and oxidation of hydrogen. Complexes with tethered amines that resemble the active...

More Comments are closed
.NET Core 1.0 released, now officially supported by Red Hat

Version 1.0 of .NET Core, the open source, cross-platform .NET runtime platform that was first announced in 2014, has been released today. .NET Core is arriving alongside ASP.NET Core 1.0, the open source, cross-platform version of Microsoft's Web development stack.

Microsoft picked an unusual venue to announce the release: the Red Hat Summit. One of the...

More Comments are closed
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

Interruption of combination antiretroviral therapy (ART) in HIV-1-infected individuals leads to rapid viral rebound. Here we report the results of a phase IIa open label clinical trial evaluating 3BNC117, a broad and potent neutralizing antibody (bNAb) against the CD4 binding site of HIV-1 Env1, in the setting of analytical treatment interruption (ATI) in 13 HIV-1-infected individuals. Participants with 3BNC117-sensitive virus outgrowth cultures were enrolled....

More Comments are closed
Unswayed by Axanar, CBS and Paramount offer 10 rules for fan film makers

CBS and Paramount, the two studios that own the rights to Star Trek, announced a list of 10 guidelines for fan film creators this week. The studios are saying that they “will not object to, or take legal action against” filmmakers that follow the new rules (although the studios added that “CBS and Paramount Pictures reserve the right to revise, revoke and/or withdraw these...

More Comments are closed